Bidirectional Glenn procedure



# Bidirectional Glenn Procedure
The Bidirectional Glenn Procedure is a type of heart surgery used primarily in the treatment of congenital heart defects. It is a palliative procedure that is often performed as part of a staged surgical approach to managing complex heart conditions, particularly those involving single ventricle physiology.
History[edit]
The Bidirectional Glenn Procedure was developed as an evolution of the original Glenn shunt, which was first described by Dr. William Glenn in 1958. The original procedure involved creating a direct connection between the superior vena cava and the right pulmonary artery, allowing for passive blood flow to the lungs. The bidirectional modification allows blood to flow to both lungs, improving oxygenation and reducing the workload on the heart.
Indications[edit]
The procedure is typically indicated for patients with congenital heart defects that result in a single functional ventricle. These conditions include:
Procedure[edit]
The Bidirectional Glenn Procedure involves the following steps:
1. Preparation: The patient is placed under general anesthesia, and the chest is opened via a median sternotomy. 2. Isolation of the Superior Vena Cava: The superior vena cava is isolated and divided. 3. Anastomosis: The superior vena cava is then anastomosed to the right pulmonary artery, allowing venous blood to flow directly into the pulmonary circulation. 4. Closure: The chest is closed, and the patient is monitored in the intensive care unit.
Outcomes[edit]
The Bidirectional Glenn Procedure is generally well-tolerated and can significantly improve the quality of life for patients with single ventricle physiology. It reduces the volume load on the heart and improves oxygenation. However, it is not a curative procedure and is often followed by the Fontan Procedure as part of a staged surgical approach.
Complications[edit]
Potential complications of the Bidirectional Glenn Procedure include:
Related Pages[edit]
| Congenital heart diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This congenital heart disease related article is a stub.
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian